Dr Reddy’s Laboratories Share Price Today: Should You Buy or Not?
- May 28, 2026
- Posted by: Kunal Singla
- Category: News
Dr Reddy’s Laboratories share price today is Rs 1322.5, having declined 0.41 percent from its previous close of Rs 1327.9 in today’s session on NSE. The Pharmaceuticals company trades under the symbol DRREDDY with a market capitalisation of Rs 1,10,000 Cr. With a day high of Rs 1346.8 and a low of Rs 1319.8, investor interest in Dr Reddy’s Laboratories is cautious heading into the close. The central question for investors is whether Dr Reddy’s Laboratories share price today offers a buying opportunity worth acting on.
Click Here – Get Free Investment Predictions on Univest
Dr Reddy’s Laboratories Company Overview
Hyderabad-based global pharmaceutical company with strong US generics, branded generics and active ingredients businesses.
| Parameter | Details (May 27, 2026) |
|---|---|
| NSE Symbol | DRREDDY |
| Sector | Pharmaceuticals |
| CMP (Live) | Rs 1322.5 |
| Today’s High | Rs 1346.8 |
| Today’s Low | Rs 1319.8 |
| Previous Close | Rs 1327.9 |
| Market Cap | Rs 1,10,000 Cr |
Dr Reddy’s Laboratories Share Price Today: Key Levels and Recent Performance
Dr Reddy’s Laboratories share price today at Rs 1322.5 has declined 0.41 percent from yesterday’s close of Rs 1327.9. Intraday trading saw a range of Rs 1319.8 to Rs 1346.8, indicating profit booking and cautious near-term sentiment. The day range gives investors reference points for entry and exit decisions on the stock.
At the current market cap of Rs 1,10,000 Cr, Dr Reddy’s Laboratories is an established player in the Pharmaceuticals space. Investors tracking Dr Reddy’s Laboratories share price today should watch the intraday high of Rs 1346.8 as immediate resistance and today’s low of Rs 1319.8 as near-term support before making investment decisions.
Dr Reddy’s Laboratories Financial Performance and Business Update
Dr Reddy’s Laboratories Revenue and Earnings Trajectory
Dr Reddy’s Laboratories has been building its revenue base through its core Pharmaceuticals business. The company’s earnings profile is shaped by demand trends in its primary markets, pricing dynamics and operating leverage as volumes scale. Investors tracking Dr Reddy’s Laboratories share price today should review the latest quarterly results for revenue growth, EBITDA margin trends and PAT performance to assess earnings momentum.
Balance Sheet and Cash Flow Indicators
Balance sheet quality including debt levels, working capital efficiency and free cash flow generation are key metrics for evaluating Dr Reddy’s Laboratories as a long-term investment. Companies in the Pharmaceuticals sector with improving return on equity and manageable debt-to-equity ratios tend to sustain long-term price appreciation and deserve premium valuations.
Management Guidance and Sector Positioning
Management commentary on order book, revenue guidance and capacity plans provides the clearest forward indicator for Dr Reddy’s Laboratories share price today’s fundamental trajectory. Sector tailwinds from India’s economic growth, infrastructure investment and policy support for the Pharmaceuticals sector provide a favourable macro backdrop for the company’s medium-term performance.
Reasons to Consider Buying Dr Reddy’s Laboratories Share Today
US Generic Market Opportunity
The US is the world’s largest generic pharmaceutical market. Indian pharma companies with FDA-approved facilities and complex generic pipelines are well positioned.
Domestic Branded Generic Growth
India’s domestic formulations market is growing at 8 to 12 percent annually, driven by increasing healthcare penetration and affordability.
Biosimilars Pipeline Potential
Companies investing in biosimilars have significant upside potential as several blockbuster biologics lose patent protection.
API Self-Reliance Drive
India’s focus on reducing API import dependence from China creates structural demand for domestic API manufacturers.
Key Risks Before Buying Dr Reddy’s Laboratories Share Today
US FDA Regulatory Risk
Adverse observations or warning letters from the US FDA can severely impact revenues from the key US market.
US Generic Price Erosion
The US generics market is highly competitive with accelerating price erosion. Revenue from specific molecules can decline sharply.
API Input Cost Volatility
Pharma companies relying on imported APIs from China face supply disruption and cost volatility risks.
Technical View on Dr Reddy’s Laboratories Share Price Today
Dr Reddy’s Laboratories share price today at Rs 1322.5 is trading below its previous close, reflecting near-term selling pressure. The intraday high of Rs 1346.8 serves as immediate resistance for bulls, while the day low of Rs 1319.8 provides the first technical support level to watch. A recovery above the previous close of Rs 1327.9 would be the first signal of stabilisation.
Investors should track key moving averages including the 20-day, 50-day and 200-day SMA relative to Dr Reddy’s Laboratories share price today to assess the broader trend direction. RSI and volume indicators alongside price action will help determine whether the current move has conviction.
Check Dr Reddy’s Laboratories live price and fundamentals on the Univest Screener
Should You Buy Dr Reddy’s Laboratories Share Today?
Dr Reddy’s Laboratories share price today at Rs 1322.5 presents a case that requires balancing sector growth potential against stock-specific valuation and risk factors. The Pharmaceuticals sector is navigating near-term challenges and Dr Reddy’s Laboratories is positioned within it with a business model that should benefit as sector conditions improve. Long-term investors with a 2 to 3 year horizon may find merit in the stock on meaningful dips, while short-term traders should define clear entry and exit levels based on technical analysis.
Any investment decision on Dr Reddy’s Laboratories share price today should be preceded by a thorough review of the latest financials, sector outlook and portfolio fit. Investors are strongly advised to consult a SEBI-registered financial advisor before making any investment decision.
Download the Univest iOS App or Univest Android App to track Dr Reddy’s Laboratories share price today and get daily stock research.
Conclusion
Dr Reddy’s Laboratories share price today at Rs 1322.5 reflects a company with a meaningful presence in India’s Pharmaceuticals sector. The structural growth drivers for the sector, combined with Dr Reddy’s Laboratories’s competitive positioning, make it a name worth tracking for long-term investors. However, valuation discipline and awareness of sector-specific risks are essential before committing capital at current levels. Monitor quarterly earnings, management commentary and sector-level developments to make informed decisions about Dr Reddy’s Laboratories share price today.
Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice.
Frequently Asked Questions on Dr Reddy’s Laboratories Share Price Today
What is Dr Reddy’s Laboratories share price today?
Ans. Dr Reddy’s Laboratories share price today is Rs 1322.5 as of May 27, 2026, with an intraday high of Rs 1346.8 and a low of Rs 1319.8. The stock has declined 0.41 percent from its previous close of Rs 1327.9. It trades on NSE under the symbol DRREDDY in the Pharmaceuticals sector.
Should I buy Dr Reddy’s Laboratories share today?
Ans. Dr Reddy’s Laboratories share price today at Rs 1322.5 requires careful analysis before investing. Consider the company’s Pharmaceuticals sector positioning, earnings trajectory and valuation relative to peers. Long-term investors may consider accumulating on dips while short-term traders should use defined stop-losses. Always consult a SEBI-registered financial advisor before investing.
What is the sector of Dr Reddy’s Laboratories?
Ans. Dr Reddy’s Laboratories belongs to the Pharmaceuticals sector and trades on NSE under symbol DRREDDY with a market capitalisation of Rs 1,10,000 Cr. Hyderabad-based global pharmaceutical company with strong US generics, branded generics and active i
What is Dr Reddy’s Laboratories share price target?
Ans. Share price targets for Dr Reddy’s Laboratories depend on earnings growth, sector tailwinds and valuation re-rating potential in the Pharmaceuticals space. Investors should track quarterly earnings and sector-level developments to assess price target milestones. Use the Univest Screener for updated analyst targets and research on Dr Reddy’s Laboratories share price today.
What is the market cap of Dr Reddy’s Laboratories today?
Ans. The market capitalisation of Dr Reddy’s Laboratories is approximately Rs 1,10,000 Cr as of May 27, 2026. The company trades on NSE under symbol DRREDDY in the Pharmaceuticals sector.
What are the key risks in Dr Reddy’s Laboratories share?
Ans. Key risks for Dr Reddy’s Laboratories include us fda regulatory risk, us generic price erosion, and api input cost volatility. Investors should carefully evaluate these risk factors alongside the growth potential before investing in Dr Reddy’s Laboratories share price today.
How to buy Dr Reddy’s Laboratories shares?
Ans. You can buy Dr Reddy’s Laboratories shares by opening a demat and trading account with a SEBI-registered broker. Search for NSE symbol DRREDDY, check Dr Reddy’s Laboratories share price today, and place a buy order at market or limit price. The Univest app provides a convenient platform to track Dr Reddy’s Laboratories live price.
Where can I track Dr Reddy’s Laboratories share price live?
Ans. You can track Dr Reddy’s Laboratories share price today live on NSE under ticker DRREDDY. The Univest Screener provides real-time data, fundamentals, FII and DII flows, and research for Dr Reddy’s Laboratories. The Univest app also delivers daily stock recommendations and Pharmaceuticals sector analysis.
